Effects of an in-patient treatment program based on regular exercise and a balanced diet on high molecular weight adiponectin, resistin levels, and insulin resistance in adolescents with severe obesity

Applied Physiology, Nutrition and Metabolism

Volumn 37, Issue 4, 2012, Pages 672-679

  Gueugnon, Carine ^a,b   Mougin, Fabienne ^a,b   Simon Rigaud, Marie Laure ^a   Regnard, Jacques ^a   Nègre, Véronique ^c   Dumoulin, Gilles ^a,d  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UPFR des Sports   (France)

^c Réseau de prise en charge et de prévention de l'obésité pediatrique   (France)

^d UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Adiponectin; Adolescents; Insulin resistance; Obesity; Physical exercise; Resistin; Weight loss

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; INSULIN; RESISTIN; RETN PROTEIN, HUMAN;

ADOLESCENT; ARTICLE; BLOOD; CHEMISTRY; CHILD HEALTH CARE; CLINICAL TRIAL; DIET THERAPY; EXERCISE; FEMALE; HEALTH CARE QUALITY; HOSPITAL PATIENT; HUMAN; INSULIN RESISTANCE; LOW CALORY DIET; MALE; METABOLISM; MOLECULAR WEIGHT; MORBID OBESITY; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADIPONECTIN; ADOLESCENT; ADOLESCENT HEALTH SERVICES; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; INPATIENTS; INSULIN; INSULIN RESISTANCE; MALE; MOLECULAR WEIGHT; OBESITY, MORBID; PROGRAM EVALUATION; RESISTIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84863753016     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/H2012-045     Document Type: Article

References (51)

1. Abbasi, F., Chang, S.A., Chu, J.W., Ciaraldi, T.P., Lamendola, C., McLaughlin, T., et al. 2006. Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290(1): R139-R144. doi:10.1152/ajpregu.00287.2005. PMID:16352858.
2. Araki, S., Dobashi, K., Kubo, K., Asayama, K., and Shirahata, A. 2006. High molecular weight, rather than total, adiponectin levels better reflect metabolic abnormalities associated with childhood obesity. J. Clin. Endocrinol. Metab. 91(12): 5113-5116. doi:10.1210/jc.2006-1051. PMID:16984991.
3. Aso, Y., Yamamoto, R., Wakabayashi, S., Uchida, T., Takayanagi, K., Takebayashi, K., et al. 2006. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes, 55(7): 1954-1960. doi:10.2337/db05-1525. PMID:16804063.
4. Balagopal, P., George, D., Yarandi, H., Funanage, V., and Bayne, E. 2005. Reversal of obesity-related hypoadiponectinemia by lifestyle intervention: a controlled, randomized study in obese adolescents. J. Clin. Endocrinol. Metab. 90(11): 6192-6197. doi:10.1210/jc.2004-2427. PMID:16131584.
5. Basu, R., Pajvani, U.B., Rizza, R.A., and Scherer, P.E. 2007. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes, 56(8): 2174-2177. doi:10.2337/db07-0185. PMID:17513700.
6. Beltowski, J. 2003. Adiponectin and resistin-new hormones of white adipose tissue. Med. Sci. Monit. 9(2): RA55-RA61. PMID: 12601307.
7. Böttner, A., Kratzsch, J., Möller, G., Kapellen, T.M., Blüher, S., Keller, E., et al. 2004. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab. 89(8): 4053-4061. doi:10.1210/jc.2004-0303. PMID:15292348.
8. Cambuli, V.M., Musiu, M.C., Incani, M., Paderi, M., Serpe, R., Marras, V., et al. 2008. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J. Clin. Endocrinol. Metab. 93(8): 3051-3057. doi:10.1210/jc.2008-0476. PMID: 18492759.
9. Elloumi, M., Ben Ounis, O., Makni, E., Van Praagh, E., Tabka, Z., and Lac, G. 2009. Effect of individualized weight-loss programmes on adiponectin, leptin and resistin levels in obese adolescent boys. Acta Paediatr. 98(9): 1487-1493. doi:10.1111/j.1651-2227.2009.01365.x. PMID:19489770.
10. Filkova, M., Haluzik, M., Gay, S., and Senolt, L. 2009. The role of resistin as a regulator of inflammation: Implications for various human pathologies. Clin. Immunol. 133(2): 157-170. doi:10.1016/j.clim.2009.07.013. PMID:19740705.
11. Gueugnon, C., Mougin, F., Nguyen, N., Bouhaddi, M., Nicolet-Guénat, M., and Dumoulin, G. 2012. Ghrelin and PYY levels in adolescents with severe obesity: effects of weight loss induced by long-term exercise training and modified food habits. Eur. J. Appl. Physiol. 112: 1797-1805. doi:10.1007/s00421-011-2154-2. PMID:21909986.
12. Hara, K., Horikoshi, M., Yamauchi, T., Yago, H., Miyazaki, O., Ebinuma, H., et al. 2006. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care, 29(6): 1357-1362. doi:10.2337/dc05-1801. PMID:16732021.
13. Hirose, H., Yamamoto, Y., Seino-Yoshihara, Y., Kawabe, H., and Saito, I. 2010. Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders. J. Atheroscler. Thromb. 17(12): 1201-1211. doi:10.5551/jat.6106. PMID:20948162.
14. Jones, T.E., Basilio, J.L., Brophy, P.M., McCammon, M.R., and Hickner, R.C. 2009. Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obesity (Silver Spring), 17(6): 1189-1195. PMID:19247279.
15. Kadowaki, T., and Yamauchi, T. 2005. Adiponectin and adiponectin receptors. Endocr. Rev. 26(3): 439-451. doi:10.1210/er.2005-0005. PMID:15897298.
16. Kaser, S., Tatarczyk, T., Stadlmayr, A., Ciardi, C., Ress, C., Tschoner, A., et al. 2008. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur. J. Clin. Invest. 38(11): 827-834. doi:10.1111/j.1365-2362.2008.02028.x. PMID: 19021700.
17. Kershaw, E.E., and Flier, J.S. 2004. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89(6): 2548-2556. doi:10.1210/jc.2004-0395. PMID:15181022.
18. Lara-Castro, C., Luo, N., Wallace, P., Klein, R.L., and Garvey, W.T. 2006. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes, 55(1): 249-259. doi:10.2337/diabetes.55.01.06.db05-1105. PMID:16380500.
19. Lazzer, S., Vermorel, M., Montaurier, C., Meyer, M., and Boirie, Y. 2005. Changes in adipocyte hormones and lipid oxidation associated with weight loss and regain in severely obese adolescents. Int. J. Obes. 29(10): 1184-1191. doi:10.1038/sj.ijo.0802977. PMID:16155586.
20. Lee, J.H., Chan, J.L., Yiannakouris, N., Kontogianni, M., Estrada, E., Seip, R., et al. 2003. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88(10): 4848-4856. doi:10.1210/jc. 2003-030519. PMID:14557464.
21. Li, M., Fisette, A., Zhao, X.Y., Deng, J.Y., Mi, J., and Cianflone, K. 2009. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int. J. Obes. 33(4): 424-439. doi:10.1038/ijo.2009.44. PMID:19290012.
22. Lihn, A.S., Pedersen, S.B., and Richelsen, B. 2005. Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 6(1): 13-21. doi:10.1111/j.1467-789X.2005.00159.x. PMID: 15655035.
23. Linscheid, P., Christ-Crain, M., Stoeckli, R., Reusch, C.E., Lutz, T.A., Muller, B., and Keller, U. 2008. Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss. Diabetes Obes. Metab. 10(12): 1266-1270. PMID:18494809.
24. Martin, A. 2001. The "apports nutritionnels conseillés (ANC)" for the French population. Reprod. Nutr. Dev. 41(2): 119-128. doi:10. 1051/rnd:2001100. PMID:11434516.
25. Martos-Moreno, G.Á., Barrios, V., Martínez, G., Hawkins, F., and Argente, J. 2010. Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity, 18(12): 2288-2294. doi:10.1038/oby.2010.68. PMID:20339359.
26. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F., and Turner, R.C. 1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7): 412-419. doi:10.1007/BF00280883. PMID:3899825.
27. Menzaghi, C., Trischitta, V., and Doria, A. 2007. Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes, 56(5): 1198-1209. doi:10.2337/db06-0506. PMID:17303804.
28. Murdolo, G., Nowotny, B., Celi, F., Donati, M., Bini, V., Papi, F., et al. 2011. Inflammatory adipokines, high molecular weight adiponectin, and insulin resistance: a population-based survey in prepubertal schoolchildren. PLoS ONE, 6(2): e17264. doi:10.1371/journal.pone.0017264. PMID:21365005.
29. Nakano, Y., Tobe, T., Choi-Miura, N.H., Mazda, T., and Tomita, M. 1996. Isolation and characterization of GBP28, a novel gelatinbinding protein purified from human plasma. J. Biochem. 120(4): 803-812. PMID:8947845.
30. Nakano, Y., Tajima, S., Yoshimi, A., Akiyama, H., Tsushima, M., Tanioka, T., et al. 2006. A novel enzyme-linked immunosorbent assay specific for high-molecular-weight adiponectin. J. Lipid Res. 47(7): 1572-1582. doi:10.1194/jlr.D600010-JLR200. PMID: 16603722.
31. Nishimura, R., Morimoto, A., Matsudaira, T., Miyashita, Y., Sano, H., Shirasawa, T., et al. 2007. Ratio of high-, medium-, and lowmolecular weight serum adiponectin to the total adiponectin value in children. J. Pediatr. 151(5): 545-547+e1-e2. PMID:17961704.
32. Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., et al. 2001. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 103(8): 1057-1063. PMID:11222466.
33. Polak, J., Kovacova, Z., Holst, C., Verdich, C., Astrup, A., Blaak, E., et al. 2008. Total adiponectin and adiponectin multimeric complexes in relation to weight loss-induced improvements in insulin sensitivity in obese women: the NUGENOB study. Eur. J. Endocrinol. 158(4): 533-541. doi:10.1530/EJE-07-0512. PMID: 18362301.
34. Reilly, M.P., Lehrke, M., Wolfe, M.L., Rohatgi, A., Lazar, M.A., and Rader, D.J. 2005. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111(7): 932-939. doi:10. 1161/01.CIR.0000155620.10387.43. PMID:15710760.
35. Reinehr, T., Roth, C., Menke, T., and Andler, W. 2004. Adiponectin before and after weight loss in obese children. J. Clin. Endocrinol. Metab. 89(8): 3790-3794. doi:10.1210/jc.2003-031925. PMID: 15292306.
36. Reinehr, T., Roth, C.L., Menke, T., and Andler, W. 2006. Resistin concentrations before and after weight loss in obese children. Int. J. Obes. 30(2): 297-301. doi:10.1038/sj.ijo.0803116. PMID: 16189500.
37. Rolland-Cachera, M.F., Cole, T.J., Sempe, M., Tichet, J., Rossignol, C., and Charraud, A. 1991. Body Mass Index variations: centiles from birth to 87 years. Eur. J. Clin. Nutr. 45(1): 13-21. PMID: 1855495.
38. Roth, C.L., Kratz, M., Ralston, M.M., and Reinehr, T. 2011. Changes in adipose-derived inflammatory cytokines and chemokines after successful lifestyle intervention in obese children. Metabolism, 60(4): 445-452. doi:10.1016/j.metabol.2010.03.023. PMID: 20494373.
39. Rubin, D.A., and Hackney, A.C. 2010. Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity. Med. Sport Sci. 55: 43-55. doi:10.1159/000321971. PMID:20956859.
40. Schraw, T., Wang, Z.V., Halberg, N., Hawkins, M., and Scherer, P.E. 2008. Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology, 149(5): 2270-2282. doi:10.1210/ en.2007-1561. PMID:18202126.
41. Shetty, G.K., Economides, P.A., Horton, E.S., Mantzoros, C.S., and Veves, A. 2004. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care, 27(10): 2450-2457. doi:10.2337/diacare.27.10.2450. PMID:15451915.
42. Silha, J.V., Krsek, M., Skrha, J.V., Sucharda, P., Nyomba, B.L., and Murphy, L.J. 2003. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149(4): 331-335. doi:10.1530/eje.0.1490331.PMID:14514348.
43. Steppan, C.M., Bailey, S.T., Bhat, S., Brown, E.J., Banerjee, R.R., Wright, C.M., et al. 2001. The hormone resistin links obesity to diabetes. Nature, 409(6818): 307-312. doi:10.1038/35053000. PMID:11201732.
44. Tanner, J.M. 1981. Growth and maturation during adolescence. Nutr. Rev. 39(2): 43-55. doi:10.1111/j.1753-4887.1981.tb06734.x. PMID:7010232.
45. Trujillo, M.E., and Scherer, P.E. 2006. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27(7): 762-778. PMID:17056740.
46. Vendrell, J., Broch, M., Vilarrasa, N., Molina, A., Gomez, J.M., Gutierrez, C., et al. 2004. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12(6): 962-971. doi:10.1038/oby.2004.118. PMID:15229336.
47. Wang, Y., Lam, K.S., Yau, M.H., and Xu, A. 2008. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem. J. 409(3): 623-633. doi:10.1042/BJ20071492. PMID:18177270.
48. Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R.E., and Tataranni, P.A. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86(5): 1930-1935. doi:10.1210/jc.86.5.1930. PMID:11344187.
49. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., et al. 2001. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7(8): 941-946. doi:10.1038/90984. PMID:11479627.
50. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., et al. 2003. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 423(6941): 762-769. doi:10.1038/nature01705. PMID:12802337.
51. Yaturu, S., Daberry, R.P., Rains, J., and Jain, S. 2006. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. Cytokine, 34(3/4): 219-223. doi:10.1016/j.cyto. 2006.05.005. PMID:16822679.